Hong Kong stock market anomaly | Lai Kai Medicine-B (02105.HK) rose by more than 9%. The results of the LAE102 Phase I SAD trial are impressive and will showcase a number of independently developed achievements in the ActRII field.
According to the Wise Finance app, Lai Kai Medicine-B (02105.HK) surged over 9%, rising 9.1% to 19.66 Hong Kong dollars with a trading volume of 64.68 million Hong Kong dollars as of the time of publication.
Latest
